Inventor · disambiguated record
B. Therese Kinsella
Also filed as: KINSELLA B THERESE
8 granted patents·3 pending applications·27 citations·filing 2013–2025
85Inventor score
Files withUNIV COLLEGE DUBLIN - NAT UNIV OF IRELAND DUBLIN5ATXA THERAPEUTICS LTD3UNIV COLLEGE DUBLIN NAT UNIV IRELAND DUBLIN2UNIV DUBLIN1
Top patents by PatentIndex Score
11 records- 0185US9388127B2Thromboxane receptor antagonistsUNIV DUBLIN·Filed 2013·Granted Jul 12, 2016·8 cites·16 claims
- 0283US9932304B2Thromboxane receptor antagonistsUNIV COLLEGE DUBLIN NAT UNIV IRELAND DUBLIN·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 0382US10357504B2Thromboxane receptor antagonistsUNIV COLLEGE DUBLIN NAT UNIV IRELAND DUBLIN·Filed 2018·Granted Jul 23, 2019·3 cites·14 claims
- 0480US9630915B2Thromboxane receptor antagonistsUNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN·Filed 2016·Granted Apr 25, 2017·3 cites·1 claims
- 0580US9522877B2Thromboxane receptor antagonistsUNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN·Filed 2016·Granted Dec 20, 2016·3 cites·5 claims
- 0678US9718781B2Methods and compounds for treating proliferative disorders and viral infectionsUNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN·Filed 2013·Granted Aug 1, 2017·4 cites·4 claims
- 0776US10966994B2Thromboxane receptor antagonistsATXA THERAPEUTICS LTD·Filed 2019·Granted Apr 6, 2021·1 cites·22 claims
- 0872US9738599B2Thromboxane receptor antagonistsUNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN·Filed 2017·Granted Aug 22, 2017·1 cites·10 claims
- 0949US2023301946A1Thromboxane receptor antagonist formulationsATXA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1045US2017298020A1Methods and compounds for treating proliferative disorders and viral infectionsUNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN·Filed 2017·Application pending·0 cites
- 1144US2025302848A1Drug-in-capsule formulations of thromboxane receptor antagonistsATXA THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when B. Therese Kinsella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →